Founded in Santa Clara, United States, Ancora Heart is a medical device company focused on developing innovative treatment options for heart failure (HF). Their core mission is to improve the quality of life for millions suffering from HF through advanced medical solutions. The company’s flagship product, the AccuCinch® Ventricular Restoration System, is the first fully percutaneous device designed to restore the enlarged left ventricle of the heart, offering new hope for patients with congestive heart failure.
Ancora Heart has garnered attention from notable investors and medical professionals due to its groundbreaking technology. The AccuCinch® System has been granted Breakthrough Device Designation by regulatory authorities, highlighting its potential impact on heart failure treatment. Through clinical studies and ongoing research, Ancora Heart continues to make significant strides in the medical field, aiming to transform the standard of care for heart failure patients worldwide.
